Literature DB >> 7694552

Distribution of cell adhesion molecules in skeletal muscle from patients with systemic lupus erythematosus.

M Pallis1, D K Robson, D O Haskard, R J Powell.   

Abstract

OBJECTIVE: To investigate the pathophysiology of perivascular mononuclear cell infiltrates observed in skeletal muscle from patients with systemic lupus erythematosus (SLE).
METHODS: Immunocytochemical techniques were used to examine frozen 5 microns sections from the quadriceps needle muscle biopsy specimens of 14 patients with SLE (including seven with infiltrates) for the expression of the cytokine inducible adhesion molecules intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin.
RESULTS: Vessels in 6/7 SLE biopsy specimens with perivascular infiltrates expressed VCAM-1 at a density of > 2 vessels/mm2 in contrast with 0/7 SLE biopsy specimens without infiltrates and 1/6 control specimens. In contrast, E-selectin expression was increased ( > 0.3 positive vessels/mm2) in SLE biopsy specimens compared with control tissue regardless of the presence of perivascular infiltration. VCAM-1 and ICAM-1 were also noted on extravascular cells in the infiltrates, being particularly prominent on the intermuscle fibre dendritic processes of CD68+ HLA-DR+ cells.
CONCLUSION: Expression of these cytokine inducible adhesion molecules may be important in the migration of mononuclear cells into skeletal muscle and may be involved in intercellular interactions within the tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694552      PMCID: PMC1005144          DOI: 10.1136/ard.52.9.667

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  24 in total

1.  A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide.

Authors:  S M Wellicome; M H Thornhill; C Pitzalis; D S Thomas; J S Lanchbury; G S Panayi; D O Haskard
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

2.  Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms.

Authors:  A W Boyd; S O Wawryk; G F Burns; J V Fecondo
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

Review 3.  Lymphocyte interactions with endothelial cells.

Authors:  Y Shimizu; W Newman; Y Tanaka; S Shaw
Journal:  Immunol Today       Date:  1992-03

Review 4.  Early events of the immune response mediated by leukocyte integrins.

Authors:  I Dransfield; A M Buckle; N Hogg
Journal:  Immunol Rev       Date:  1990-04       Impact factor: 12.988

5.  Muscle, nerve, and synovial changes in lupus erythematosus.

Authors:  E W LOWMAN
Journal:  Ann Rheum Dis       Date:  1951-03       Impact factor: 19.103

6.  Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy.

Authors:  J N Whitaker; W K Engel
Journal:  N Engl J Med       Date:  1972-02-17       Impact factor: 91.245

7.  Human memory T cells express intercellular adhesion molecule-1 which can be increased by interleukin 2 and interferon-gamma.

Authors:  A M Buckle; N Hogg
Journal:  Eur J Immunol       Date:  1990-02       Impact factor: 5.532

8.  Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues.

Authors:  G E Rice; J M Munro; C Corless; M P Bevilacqua
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

9.  The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: a comparison of ultraviolet B erythema and delayed hypersensitivity.

Authors:  P Norris; R N Poston; D S Thomas; M Thornhill; J Hawk; D O Haskard
Journal:  J Invest Dermatol       Date:  1991-05       Impact factor: 8.551

10.  A monoclonal antibody directed against the human intercellular adhesion molecule (ICAM-1) modulates the release of tumor necrosis factor-alpha, interferon-gamma and interleukin 1.

Authors:  D Geissler; S Gaggl; J Möst; R Greil; M Herold; M Dietrich
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

View more
  6 in total

1.  Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings.

Authors:  Mohamed Ismail Abd-Elkareem; Hegazy Mogahed Al Tamimy; Osama A Khamis; Salama S Abdellatif; Mahmoud Rezk Abdelwahed Hussein
Journal:  Clin Exp Nephrol       Date:  2010-08-17       Impact factor: 2.801

2.  Identification of MAMDC1 as a candidate susceptibility gene for systemic lupus erythematosus (SLE).

Authors:  Anna Hellquist; Marco Zucchelli; Cecilia M Lindgren; Ulpu Saarialho-Kere; Tiina M Järvinen; Sari Koskenmies; Heikki Julkunen; Päivi Onkamo; Tiina Skoog; Jaana Panelius; Anne Räisänen-Sokolowski; Taina Hasan; Elisabeth Widen; Iva Gunnarson; Elisabet Svenungsson; Leonid Padyukov; Ghazaleh Assadi; Linda Berglind; Ville-Veikko Mäkelä; Katja Kivinen; Andrew Wong; Deborah S Cunningham Graham; Timothy J Vyse; Mauro D'Amato; Juha Kere
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

3.  Differential roles of ICAM-1 and VCAM-1 in leukocyte-endothelial cell interactions in skin and brain of MRL/faslpr mice.

Authors:  M Ursula Norman; Will G James; Michael J Hickey
Journal:  J Leukoc Biol       Date:  2008-04-21       Impact factor: 4.962

4.  Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study.

Authors:  P E Spronk; H Bootsma; M G Huitema; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

Review 5.  Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA; Leukothera®): Mechanisms of Action and Therapeutic Applications.

Authors:  Brian A Vega; Benjamin A Belinka; Scott C Kachlany
Journal:  Toxins (Basel)       Date:  2019-08-26       Impact factor: 4.546

6.  ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus.

Authors:  Ioannis Parodis; Sirisha Gokaraju; Agneta Zickert; Kamala Vanarsa; Ting Zhang; Deena Habazi; João Botto; Clara Serdoura Alves; Panagiotis Giannopoulos; Anders Larsson; Elisabet Svenungsson; Iva Gunnarsson; Chandra Mohan
Journal:  Rheumatology (Oxford)       Date:  2020-09-01       Impact factor: 7.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.